Checkpoint-Engineered Particles Induce Food Allergy Tolerance

AI Tool Guides Care for Cancer Heart Attacks

Mini-Clinical Evaluation Exercise Improves Resident Self-Assessment

GLP-1 RAs Reduce Adverse Limb Events in Patients with Diabetes

Month in pharma news, explained – January 2026

EMJ’s Latest Flagship Journal

AI Models Combine Genomics and Demographics to Predict Gastric Cancer Risk

Prenatal Clues to Situs Inversus Totalis

Data Support Outpatient Stem-Cell Mobilisation Safety

Age Identified as Key Predictor of Mortality in Cirrhotic Patients

Rollout of AI Scribe Tools Transform NHS Consultations

Nomogram Predicts Atrial Fibrillation Recurrence After Cryoballoon Ablation

HPV Vaccine Gaps Leave 1 in 4 School-Leavers Vulnerable

SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes

Hemorrhagic vs Ischemic Stroke Outcomes Diverge

Onc Now: A Career at the Cutting Edge of Nuclear Medicine

Computer-Aided Detection Chest X-Ray Matches Radiologists

Light-Triggered Microneedle Patch Aimed at IVF Injections

Do GLP-1 Receptor Agonists Raise Chronic Cough Risk?

The first and only approved dual inhibitor of IL-17A and IL-17F1-6

Immunohistochemical Biomarkers for Prognostic Stratification in Metastatic Prostate Cancer